Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16740 | 28214524 | Gastroenterology | Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16742 | 28213828 | Eur J Pediatr | Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis. | 2017 | Details |
| A16746 | 28212301 | Mar Drugs | The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH. | 2017 | Details |
| A16763 | 28195177 | Am J Gastroenterol | Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. | 2017 | Details |
| A16774 | 28185715 | Clin Ther | Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16781 | 28180059 | Mol Metab | JNK at the crossroad of obesity, insulin resistance, and cell stress response. | 2016 | Details |
| A16785 | 28178440 | Rambam Maimonides Med J | Comorbidities in Patients with Psoriatic Arthritis. | 2017 | Details |
| A16797 | 28167326 | Diabetes Res Clin Pract | Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus. | 2016 | Details |
| A16810 | 28160250 | Curr Treat Options Gastroenterol | Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. | 2017 | Details |
| A16816 | 28155627 | Curr Vasc Pharmacol | Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity. | 2017 | Details |
| A16821 | 28152105 | PLoS One | Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. | 2017 | Details |
| A16823 | 28149317 | ARYA Atheroscler | Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. | 2016 | Details |
| A16830 | 28142230 | Korean J Intern Med | Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. | 2017 | Details |
| A16841 | 28133479 | Gastroenterol Res Pract | Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2017 | Details |
| A16852 | 28126503 | Presse Med | [Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences]. | 2017 | Details |
| A16862 | 28123936 | Mol Metab | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. | 2016 | Details |
| A16866 | 28120721 | Curr Pharm Des | Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension. | 2017 | Details |
| A16867 | 28120165 | J Inherit Metab Dis | Investigating the link of ACAD10 deficiency to type 2 diabetes mellitus. | 2017 | Details |
| A16882 | 28112071 | J Dev Orig Health Dis | Early life programming and the risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16884 | 28111263 | Pharmacol Res | An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. | 2017 | Details |
| A16903 | 28103626 | Hepatology | Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. | 2017 | Details |
| A16908 | 28099601 | An Bras Dermatol | Psoriasis comorbidities: complications and benefits of immunobiological treatment. | 2017 | Details |
| A16909 | 28099469 | PLoS One | The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study. | 2017 | Details |
| A16910 | 28098910 | Mol Med Rep | Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. | 2017 | Details |
| A16925 | 28089623 | Dig Liver Dis | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | 2016 | Details |
| A16940 | 28082742 | Exp Mol Med | Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. | 2017 | Details |
| A16947 | 28078997 | Curr Med Chem | Lipoprotein (a) and Cardiovascular Risk: The Show Must go on. | 2017 | Details |
| A16948 | 28077863 | Int J Obes (Lond) | What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? | 2017 | Details |
| A16955 | 28075092 | Am Fam Physician | Diabetes Mellitus: Management of Gastrointestinal Complications. | 2016 | Details |
| A16971 | 28069746 | Postgrad Med J | Non-alcoholic fatty pancreas disease. | 2017 | Details |
| A16982 | 28064001 | Biochim Biophys Acta Mol Cell Res | Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. | 2017 | Details |
| A16988 | 28062870 | Rev Gastroenterol Peru | [Metabolic parameters in patients with steatosis non alcoholic liver and controlled diabetes type 2 versus uncontrolled diabetes type 2]. | 2017 | Details |
| A17001 | 28053201 | Br J Sports Med | Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. | 2017 | Details |
| A17024 | 28038998 | Toxicol Appl Pharmacol | Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. | 2016 | Details |
| A17026 | 33442082 | J ASEAN Fed Endocr Soc | Diabetes Mellitus and Prediabetes in Patients with Hepatocellular Carcinoma in a Tertiary Philippine Hospital. | 2017 | Details |
| A17033 | 29716685 | Acta Medica (Hradec Kralove) | SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD? | 2018 | Details |
| A17036 | 29511464 | Gastroenterol Hepatol Bed Bench | Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A17044 | 28032449 | Diabetes Metab Res Rev | Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A17054 | 28025996 | Int J Mol Med | Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17056 | 28019064 | Hepatol Res | Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus. | 2017 | Details |
| A17060 | 28017576 | Prim Care Diabetes | Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients. | 2016 | Details |
| A17072 | 28008583 | Exp Clin Endocrinol Diabetes | EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography. | 2016 | Details |
| A17077 | 28003718 | J Clin Exp Hepatol | Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience. | 2016 | Details |
| A17078 | 28003715 | J Clin Exp Hepatol | High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. | 2016 | Details |
| A17080 | 28002036 | Rom J Intern Med | Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis. | 2016 | Details |
| A17081 | 28001263 | Rev Assoc Med Bras (1992) | Current management of non-alcoholic fatty liver disease. | 2016 | Details |
| A17089 | 27997977 | Semin Liver Dis | Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin. | 2016 | Details |
| A17103 | 27990792 | Minerva Endocrinol | Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne. | 2016 | Details |
| A17105 | 27989517 | Diabetes Metab Syndr | Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. | 2016 | Details |
| A17107 | 27988872 | Drugs | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease. | 2017 | Details |
| A17121 | 27981615 | Hepatology | Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. | 2017 | Details |
| A17123 | 27980597 | Nutr Metab (Lond) | Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. | 2016 | Details |
| A17124 | 27980239 | Endocr J | Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. | 2016 | Details |
| A17130 | 27974597 | Nutr Rev | What is the appropriate upper limit for added sugars consumption? | 2017 | Details |
| A17152 | 27956792 | World J Gastroenterol | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. | 2016 | Details |
| A17162 | 27939359 | Pharmacol Res | A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? | 2016 | Details |
| A17168 | 27936230 | PLoS One | The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients. | 2016 | Details |
| A17181 | 27925353 | Hepatol Res | Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
| A17190 | 27920470 | World J Gastroenterol | Nonalcoholic fatty liver disease - A multisystem disease? | 2016 | Details |
| A17198 | 27917557 | Hepatol Res | Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
| A17201 | 27916783 | Endocr J | Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial. | 2016 | Details |
| A17207 | 27914133 | J Korean Med Sci | Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness. | 2017 | Details |
| A17221 | 27906428 | Eur Rev Med Pharmacol Sci | The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. | 2016 | Details |
| A17238 | 27895393 | World J Gastroenterol | Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease. | 2016 | Details |
| A17239 | 27895389 | J Clin Biochem Nutr | Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
| A17240 | 27894410 | Cell Mol Biol (Noisy-le-grand) | Association of HFE gene mutations with nonalcoholic fatty liver disease in the Iranian population. | 2016 | Details |
| A17242 | 27893763 | PLoS One | The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. | 2016 | Details |
| A17250 | 27889809 | Diabetologia | Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study. | 2016 | Details |
| A17273 | 27872642 | Int J Endocrinol | Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. | 2016 | Details |
| A17303 | 27856445 | Am J Epidemiol | Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A17326 | 27843095 | EBioMedicine | Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy. | 2016 | Details |
| A17332 | 31435207 | J Taibah Univ Med Sci | The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus. | 2016 | Details |
| A17338 | 27835657 | PLoS One | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. | 2016 | Details |
| A17347 | 27832040 | Eur J Gastroenterol Hepatol | Short article: A randomized-controlled study of sitagliptin for treating diabetes mellitus complicated by nonalcoholic fatty liver disease. | 2017 | Details |
| A17353 | 27827899 | Nutrients | Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding. | 2016 | Details |
| A17364 | 27823604 | Endocrinol Metab Clin North Am | Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus. | 2016 | Details |
| A17373 | 27821024 | Acta Gastroenterol Belg | Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients. | 2017 | Details |
| A17383 | 27812974 | Exp Suppl | Structure and Regulation of AMPK. | 2017 | Details |
| A17386 | 27810989 | Diabetes Care | Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference. | 2016 | Details |
| A17391 | 27459528 | J Clin Endocrinol Metab | One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects. | 2016 | Details |
| A17395 | 27729660 | Nat Rev Gastroenterol Hepatol | NAFLD and diabetes mellitus. | 2016 | Details |
| A17397 | 27636730 | Nat Rev Endocrinol | PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. | 2016 | Details |
| A17398 | 27527741 | Am J Gastroenterol | Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. | 2016 | Details |
| A17403 | 27656762 | Gut Microbes | Hypogonadism alters cecal and fecal microbiota in male mice. | 2016 | Details |
| A17404 | 27181828 | J Diabetes Investig | Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications. | 2016 | Details |
| A17407 | 27760050 | J Clin Invest | Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. | 2016 | Details |
| A17409 | 27797398 | Eur J Clin Invest | Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. | 2016 | Details |
| A17412 | 27796056 | J Gastroenterol Hepatol | Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis. | 2017 | Details |
| A17415 | 27397679 | Endocr J | The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. | 2016 | Details |
| A17416 | 30148574 | Lijec Vjesn | [NONALCOHOLIC FATTY LIVER DISEASE – A MULTISYSTEM DISEASE?]. | 2018 | Details |
| A17418 | 27794176 | Hepatol Res | High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus. | 2016 | Details |
| A17423 | 27788733 | Zhonghua Gan Zang Bing Za Zhi | [Fine particulate matter and nonalcoholic fatty liver disease]. | 2016 | Details |
| A17429 | 27788706 | Zhonghua Gan Zang Bing Za Zhi | [Effects of celecoxib on expression of PPARγ and NF-κB in type 2 diabetes rats with non-alcoholic steatohepatitis]. | 2016 | Details |
| A17431 | 27769711 | Chem Biol Interact | Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet. | 2016 | Details |
| A17433 | 27647227 | Tumori | Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients. | 2016 | Details |
| A17439 | 27787945 | J Diabetes | Personalized microbiome-based approaches to metabolic syndrome management and prevention. | 2017 | Details |
| A17446 | 27600089 | Eur J Clin Invest | Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations. | 2016 | Details |
| A17448 | 26971094 | J Gastroenterol | Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17487 | 27768965 | Int J Cardiol | Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. | 2016 | Details |
| A17491 | 27765690 | Gastroenterology | Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. | 2016 | Details |